The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 09, 2024
Filed:
Sep. 01, 2021
Applicant:
Otsuka Pharmaceutical Co., Ltd., Tokyo, JP;
Inventors:
Paul Anthony Baguley, Didcot, GB;
Colin Thomas Lindley, Stanford In The Vale, GB;
Robert Craig Melling, Didcot, GB;
Assignee:
OTSUKA PHARMACEUTICAL CO., LTD., Tokyo, JP;
Primary Examiner:
Int. Cl.
CPC ...
C07D 405/14 (2006.01); A61K 9/00 (2006.01); A61K 9/19 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 47/10 (2017.01);
U.S. Cl.
CPC ...
C07D 405/14 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 9/19 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/4858 (2013.01); A61K 47/10 (2013.01); C07B 2200/13 (2013.01);
Abstract
This invention relates to the compound (2R)-2-(6-{5-chloro-2-[(oxan-4-yl)amino]pyrimidin-4-yl}-1-oxo-2,3-dihydro-1H-isoindol-2-yl)-N-[(1S)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl]propanamide, and in particular to novel physical forms of the compound, a process for preparing the compound and synthetic intermediates for use in the process, and novel formulations containing the compound, as well as therapeutic uses of the compound.